X

CPIC Guideline Endorsement

Author: [AUTHOR] Published on 2/26/2018 4:57:00 PM

The following CPIC Guidelines have recently been endorsed by the ASCPT Board of Directors.

Clinical Pharmacogenetics Implementation Consortium (CPIC)Guideline for Dihydropyrimidine Dehydrogenase Genotype and Fluoropyrimidine Dosing: 2017 Update

Clinical Pharmacogenetics Implementation Consortium (CPIC)Guideline for CYP2D6 and Tamoxifen Therapy

Clinical Pharmacogenetics Implementation Consortium (CPIC)Guideline for HLA Genotype and Use of Carbamazepine and Oxcarbazepine: 2017 Update

print
Sort by:
Photo Gallery
Recent News
  • How Do You Develop a Bispecific Antibody for the Treatment of B-cell Non-Hodgkin Lymphoma? A Review of Key Lessons From Approved CD20×CD3 Products
    November 24, 2025
  • Guiding Drug Developers in Therapeutic Peptide Projects: Insights to Drug-Drug Interaction Risks from Recent Approvals
    November 18, 2025
  • ASCPT Adviser: November 2025
    November 13, 2025
Contact Us